Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1.

Failure to reepithelialize is the major clinical problem in venous ulcers. It is not clear whether the problem resides with keratinocytes or with inadequate and improper formation of extracellular matrix. In this study, we characterized the biosynthetic activity and response to transforming growth factor-beta 1 (TGF-beta) of dermal fibroblast cultures isolated from biopsies of venous ulcers and from normal thigh skin (controls) of seven patients. We found that baseline 3H-proline incorporation was similar in fibroblasts from venous ulcers and control skin (p= 0.1716). No difference was detected by ELISA between ulcer and control fibroblasts in the synthesis of total TGF-beta (p = 0.2309), and the mRNA levels for alpha 1(I) procollagen and TGF-beta were comparable in both groups. However, TGF-beta (0.1-5 ng/ml) enhanced collagen protein synthesis by more than 60% and in a dose-dependent manner (r = 0.997) in control fibroblast cultures, while failing to stimulate collagen production by venous ulcer fibroblasts (p = 0.0001). This unresponsiveness to TGF-beta was associated with up to a fourfold decrease in TGF-beta Type II receptors. We conclude that fibroblasts from the edge of non-healing venous ulcers are unresponsive to the action of TGF-beta, and that this blunted response may cause faulty deposition of the extracellular matrix needed for reepithelialization and wound healing.

[1]  J. Kruskal,et al.  Fibrin- and fibrinogen-related antigens in patients with venous disease and venous ulceration. , 1991, Archives of dermatology.

[2]  D. M. Cooper,et al.  Safety and effect of transforming growth factor‐β2 for treatment of venous stasis ulcers , 1995, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[3]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[4]  T. Fahey,et al.  Differential TNF secretion by wound fibroblasts compared to normal fibroblasts in response to LPS. , 1995, The Journal of surgical research.

[5]  B. Gilchrest,et al.  Experimental approaches to chronic wounds , 1995, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[6]  F A Auger,et al.  Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts. , 1994, The Journal of surgical research.

[7]  M. Sporn,et al.  Hypoxia upregulates the synthesis of tgf-β1 by human dermal fibroblasts , 1991 .

[8]  J. Dormandy,et al.  Causes of venous ulceration: a new hypothesis , 1988 .

[9]  H. Takagi,et al.  Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic. , 1995, The Journal of clinical investigation.

[10]  R. Kirsner,et al.  Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts , 1993, Journal of cellular physiology.

[11]  M. Sporn,et al.  Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. , 1987, Science.

[12]  W. Harvey,et al.  A quantitative assay for collagen synthesis in microwell fibroblast cultures. , 1979, Analytical biochemistry.

[13]  J. Myers,et al.  Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. , 1982, Nucleic acids research.

[14]  A. Roberts,et al.  Transforming growth factor‐β: activity and efficacy in animal models of wound healing , 1995, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[15]  J. Peltonen,et al.  Platelet-derived growth factor isoforms PDGF-AA, -AB and -BB exert specific effects on collagen gene expression and mitotic activity of cultured human wound fibroblasts. , 1995, Biochemical and biophysical research communications.

[16]  Anita B. Roberts,et al.  Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells , 1985, Nature.

[17]  W. Eaglstein,et al.  The "trap" hypothesis of venous ulceration , 1993, The Lancet.

[18]  K. Burnand,et al.  THE CAUSE OF VENOUS ULCERATION , 1982, The Lancet.

[19]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[20]  F. Grinnell,et al.  Degradation of Fibronectin and Vitronectin and Vitronectin in Chronic Wound Fluid: Analysis by Cell Blotting, Immunoblotting, and Cell Adhesion Assays , 1992 .

[21]  R. Weinberg,et al.  Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.

[22]  V. Falanga,et al.  Extravasation of macromolecules and possible trapping of transforming growth factor‐β in venous ulceration , 1995, The British journal of dermatology.

[23]  C. McCollum,et al.  Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions. , 1996, The Journal of investigative dermatology.